Publication | Closed Access
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias
49
Citations
20
References
2014
Year
Hematological MalignancyAdvanced LeukemiasAkt Inhibitor TerameprocolMedicineImmunologyImmune Checkpoint InhibitorAdult T-cell Leukemia-lymphomaNovel Cdc2/cdk1OncologyRadiation OncologyNovel TherapyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1